PT  - JOURNAL ARTICLE
AU  - Matías Arim
AU  - Daniel Herrera-Esposito
AU  - Paola Bermolen
AU  - Álvaro Cabana
AU  - María Inés Fariello
AU  - Mauricio Lima
AU  - Hector Romero
TI  - Containment to outbreak tipping points in COVID-19
AID  - 10.1101/2020.09.14.20194159
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.09.14.20194159
4099  - http://medrxiv.org/content/early/2020/09/15/2020.09.14.20194159.short
4100  - http://medrxiv.org/content/early/2020/09/15/2020.09.14.20194159.full
AB  - Non-pharmaceutical interventions (NPIs) have been a cornerstone in managing emergent diseases such as COVID-191–4. However, despite their potential to contain or attenuate the epidemic, the effects of NPIs on disease dynamics are not well understood1,5–7. We show that saturation of NPIs with the increase in infected individuals, an expected consequence of limited contact tracing and healthcare capacities, produces a positive feedback in the disease growth rate and a threshold between two alternative states--containment and outbreak8. These alternative states were previously related with the strength of NPIs but not with the infection number2,9–11. Furthermore, the transition between these states involves an abrupt acceleration in disease dynamics, which we report here for several COVID-19 outbreaks around the world. The consequences of a positive feedback in population dynamics at low numbers is a phenomenon widely studied in ecology--the Allee effect. This effect is a determinant of extinction-outbreak states, geographic synchronization, spatial spread, and the effect of exogenous variables, as vaccination12–15. As countries are relaxing containing measures, recognizing an NPI-induced Allee effect may be essential for deploying containment strategies within and among countries16 and acknowledges the need for early warning indicators of approaching epidemic tipping points17.Competing Interest StatementThe authors have declared no competing interest.Funding StatementMA. thanks CSIC groups-657725. This work was partially supported by CSIC-UdelaR, PEDECIBA and ANII. Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:No human analyses were primarily conducted in this studyAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData Availability Country and regional COVID-19 daily data and demographic data were obtained from Johns Hopkins University COVID-19 Data Repository31. Code Availability All the code used in this work is available at https://github.com/almadana/alle.covid/. https://github.com/almadana/alle.covid/